Chemomab Therapeutics CMMB
NASDAQ CMMB
$1.18 +0.01 (+0.85%)
At close: Oct 20, 2026 · 4:00 PM EDT

Chemomab Therapeutics (CMMB) Receivables - Other (2011 - 2018)

Updated

Chemomab Therapeutics' Receivables - Other came in at $21,000 for Q4 2018, up 40.0% from $15,000 a year earlier.

Analysis

Chemomab Therapeutics (CMMB) Receivables - Other (2011 - 2018) Analysis & Trends

  • Going back by year, Receivables - Other was $15,000 in FY2017.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,146.94 Bn 1,115.53 Bn 19.71 Bn
2 Johnson & Johnson 624.96 Bn 543.49 Bn 17.26 Bn
3 AbbVie 510.15 Bn 483.27 Bn 12.70 Bn
4 Merck 366.13 Bn 320.51 Bn 12.21 Bn
5 Novartis Ag 297.75 Bn 261.74 Bn 11.24 Bn
6 Astrazeneca 261.93 Bn 235.62 Bn 12.86 Bn
7 Amgen 236.51 Bn 191.91 Bn 7.24 Bn
8 Gilead Sciences 194.27 Bn 168.47 Bn 6.22 Bn
9 Pfizer 171.74 Bn 118.39 Bn 10.94 Bn
10 Chemomab Therapeutics 7.49 Mn -27.66 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2018 21,000.00
Dec 31, 2017 15,000.00
Dec 31, 2012 70,333.68
Sep 30, 2012 335,426.01
Jun 30, 2012 733,292.70
Dec 31, 2011 -352,882.46
Sep 30, 2011 -506,040.26
Jun 30, 2011 -93,438.78
API Access

Chemomab Therapeutics Receivables - Other API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=receivables-other&ticker=CMMB&period=max&api_key=YOUR_API_KEY